Researchers confirm dosing, efficacy of pediatric HIV drug combination
August 03, 2023 2 min read Source/Disclosures Disclosures: Brooks reports receiving consulting fees from ViiV Healthcare. Please see the study
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Author: Evan Vega
Doctors Sound Alarm About Child Nicotine Poisoning as Vapes Flood the US Market
Hospital toxicologist Ryan Marino has seen up close the violent reactions of children poisoned by liquid nicotine from electronic cigarettes.
Read More
Toxoplasmosis Infection from a Brain Parasite
Nearly one quarter of Americans have already been infected with the brain parasite toxoplasma. Toxoplasma is a brain parasite that
Read More
‘Conscience’ Bills Let Medical Providers Opt Out of Providing a Wide Range of Care
Carly Graf A new Montana law will provide sweeping legal protections to health care practitioners who refuse to prescribe marijuana
Read More
Increasing COVID vaccine, booster uptake in Black patients requires empathy, conversation
August 01, 2023 1 min read Source/Disclosures Published by: Disclosures: Ezeh reports no relevant financial disclosures. Please see the study
Read More
Tydemy birth control pill may not be effective, FDA warns
Signage is seen outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, Aug. 29, 2020. Andrew Kelly
Read More
One in six toddlers did not complete childhood vaccination series before COVID-19
August 02, 2023 3 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read More
NIH picks Marrazzo to replace Fauci as head of NIAID
August 02, 2023 1 min read Source/Disclosures Published by: Disclosures: Tabak reports no relevant financial disclosures. ADD TOPIC TO EMAIL
Read More
CVS Health (CVS) Q2 2023 earnings
A customer exits a CVS Health Corp. store in Oakland, California, U.S., on Friday, Aug. 2, 2019. Michael Short |
Read More
The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system
Read More